Fall 2019 Newsletter
Fall 2019 Newsletter
A Note from the President
Fall has arrived and the days are getting shorter, but our scientists here at TransPharm are still working around the clock to make sure your studies run smoothly. The cooler days remind us that winter is just around the corner and we’d like to give you advanced notice of our holiday hours. TransPharm will close at the end of business on Friday, December 20th and re-open on Thursday, January 2nd. Signed quotes must be received by Thursday, December 19th for studies scheduled to run the week of January 6th. We look forward to working with you in 2020!
Daniel Ross
President & CEO
In the Lab
TransPharm has purchased a nebulizer and is now offering treatment via inhalation in both mice and rats. Our new Aeroneb Pro Nebulizer, in combination with CH Technologies Oral-Nasal Aerosol and Respiratory Exposure System (ONARES), provides exceptional aerosol delivery to 12 animals simultaneously. We have validated several pathogens in our pulmonary infection model and are prepared to conduct efficacy testing of your novel antimicrobial therapeutics. Contact us today for a complimentary consultation and a free, no-obligation quote.
Santiago R. Lopez, Ph.D.
Chief Scientific Officer
Recently Validated Models
Four local college students participated in TransPharm’s 2019 summer internship program. Their work helped to validate the four new mouse models of urinary tract infection (UTI) listed below.
- P. aeruginosa (ATCC 27853) in immunocompetent BALB/c mice
- P. aeruginosa (ATCC 15692) in immunocompetent C3H/HeN mice with ciprofloxacin as a positive control
- K. pneumoniae (ATCC BAA-2146) in immunocompetent C3H/HeN mice with colistin sulfate as a positive control
TransPharm Sponsors All Sports Spectacular
TransPharm sponsored one of the most popular raffle prizes at the event, a gun safe to promote responsible storage of firearms.
President and CEO, Daniel Ross, poses with his wife and Operations Manager, Samantha Ross at the 2019 All Sports Spectacular.
Contact Us
